In the News: Meningitis FAQ's - Monadnock Community Hospital

MCH’s highest priority is the safety of our patients and we are fully and proactively engaged in this effort. Beyond those medications directly linked to cases of meningitis, the FDA, on October 15^th, advised hospitals across the US to contact patients that receivedany injectable drug from the NECC produced after May 21^st, 2012 to see if they have experienced any unusual symptoms or reactions. MCH patients who have received any of these injectable drugs from the NECC will be contacted and given specific instructions to assist us in gathering patient information as we assist the FDA in their data collection. To date, the FDA has not been able to confirm any additional cases of infection have been caused by NECC products beyond the original product directly linked to the meningitis outbreak. Again, the product linked to meningitis from the NECC has never been used here at MCH.

Download our Fungal Meningitis FAQs document (PDF)

WP_Query Object ( [query] => Array ( [page] => [name] => in-the-news-meningitis-faqs ) [query_vars] => Array ( [page] => 0 [name] => in-the-news-meningitis-faqs [error] => [m] => [p] => 0 [post_parent] => [subpost] => [subpost_id] => [attachment] => [attachment_id] => 0 [pagename] => [page_id] => 0 [second] => [minute] => [hour] => [day] => 0 [monthnum] => 0 [year] => 0 [w] => 0 [category_name] => [tag] => [cat] => [tag_id] => [author] => [author_name] => [feed] => [tb] => [paged] => 0 [meta_key] => [meta_value] => [preview] => [s] => [sentence] => [title] => [fields] => [menu_order] => [embed] => [category__in] => Array ( ) [category__not_in] => Array ( ) [category__and] => Array ( ) [post__in] => Array ( ) [post__not_in] => Array ( ) [post_name__in] => Array ( ) [tag__in] => Array ( ) [tag__not_in] => Array ( ) [tag__and] => Array ( ) [tag_slug__in] => Array ( ) [tag_slug__and] => Array ( ) [post_parent__in] => Array ( ) [post_parent__not_in] => Array ( ) [author__in] => Array ( ) [author__not_in] => Array ( ) [search_columns] => Array ( ) [ignore_sticky_posts] => [suppress_filters] => [cache_results] => 1 [update_post_term_cache] => 1 [update_menu_item_cache] => [lazy_load_term_meta] => 1 [update_post_meta_cache] => 1 [post_type] => [posts_per_page] => 12 [nopaging] => [comments_per_page] => 50 [no_found_rows] => [order] => DESC ) [tax_query] => [meta_query] => WP_Meta_Query Object ( [queries] => Array ( ) [relation] => [meta_table] => [meta_id_column] => [primary_table] => [primary_id_column] => [table_aliases:protected] => Array ( ) [clauses:protected] => Array ( ) [has_or_relation:protected] => ) [date_query] => [queried_object] => WP_Post Object ( [ID] => 419 [post_author] => 9192192 [post_date] => 2012-10-19 12:21:11 [post_date_gmt] => 2012-10-19 16:21:11 [post_content] =>

On October 6^th New England Compounding Pharmacy (NECC), announced a recall of all of its products that were compounded at and distributed from its facility in Framingham, Massachusetts. One of those products (preservative-free methylprednisolone acetate) , produced in three lots, has been linked to a national meningitis outbreak. None of the NECC’s medication directly linked to the meningitis outbreak has ever been utilized here at MCH. Monadnock Community Hospital has an excellent track record of safety with our patients. Prior to the FDA alert, MCH proactively removed all products from use that came from New England Compounding Center. MCH’s highest priority is the safety of our patients and we are fully and proactively engaged in this effort. Beyond those medications directly linked to cases of meningitis, the FDA, on October 15^th, advised hospitals across the US to contact patients that receivedany injectable drug from the NECC produced after May 21^st, 2012 to see if they have experienced any unusual symptoms or reactions. MCH patients who have received any of these injectable drugs from the NECC will be contacted and given specific instructions to assist us in gathering patient information as we assist the FDA in their data collection. To date, the FDA has not been able to confirm any additional cases of infection have been caused by NECC products beyond the original product directly linked to the meningitis outbreak. Again, the product linked to meningitis from the NECC has never been used here at MCH. Download our Fungal Meningitis FAQs document (PDF) [post_title] => In the News: Meningitis FAQ's [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => in-the-news-meningitis-faqs [to_ping] => [pinged] => [post_modified] => 2023-12-27 12:49:50 [post_modified_gmt] => 2023-12-27 17:49:50 [post_content_filtered] => [post_parent] => 0 [guid] => http://monadnockcommunityhospital.com/?p=419 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [queried_object_id] => 419 [request] => SELECT wp_posts.ID FROM wp_posts WHERE 1=1 AND wp_posts.post_name = 'in-the-news-meningitis-faqs' AND wp_posts.post_type = 'post' ORDER BY wp_posts.post_date DESC [posts] => Array ( [0] => WP_Post Object ( [ID] => 419 [post_author] => 9192192 [post_date] => 2012-10-19 12:21:11 [post_date_gmt] => 2012-10-19 16:21:11 [post_content] =>

On October 6^th New England Compounding Pharmacy (NECC), announced a recall of all of its products that were compounded at and distributed from its facility in Framingham, Massachusetts. One of those products (preservative-free methylprednisolone acetate) , produced in three lots, has been linked to a national meningitis outbreak. None of the NECC’s medication directly linked to the meningitis outbreak has ever been utilized here at MCH. Monadnock Community Hospital has an excellent track record of safety with our patients. Prior to the FDA alert, MCH proactively removed all products from use that came from New England Compounding Center. MCH’s highest priority is the safety of our patients and we are fully and proactively engaged in this effort. Beyond those medications directly linked to cases of meningitis, the FDA, on October 15^th, advised hospitals across the US to contact patients that receivedany injectable drug from the NECC produced after May 21^st, 2012 to see if they have experienced any unusual symptoms or reactions. MCH patients who have received any of these injectable drugs from the NECC will be contacted and given specific instructions to assist us in gathering patient information as we assist the FDA in their data collection. To date, the FDA has not been able to confirm any additional cases of infection have been caused by NECC products beyond the original product directly linked to the meningitis outbreak. Again, the product linked to meningitis from the NECC has never been used here at MCH. Download our Fungal Meningitis FAQs document (PDF) [post_title] => In the News: Meningitis FAQ's [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => in-the-news-meningitis-faqs [to_ping] => [pinged] => [post_modified] => 2023-12-27 12:49:50 [post_modified_gmt] => 2023-12-27 17:49:50 [post_content_filtered] => [post_parent] => 0 [guid] => http://monadnockcommunityhospital.com/?p=419 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 1 [current_post] => -1 [before_loop] => [in_the_loop] => [post] => WP_Post Object ( [ID] => 419 [post_author] => 9192192 [post_date] => 2012-10-19 12:21:11 [post_date_gmt] => 2012-10-19 16:21:11 [post_content] =>

WP_Post Object ( [ID] => 419 [post_author] => 9192192 [post_date] => 2012-10-19 12:21:11 [post_date_gmt] => 2012-10-19 16:21:11 [post_content] =>

Array ( [_yoast_wpseo_linkdex] => Array ( [0] => 71 ) [_edit_last] => Array ( [0] => 9192204 ) [_edit_lock] => Array ( [0] => 1703699335:9192204 ) [_yoast_wpseo_focuskw] => Array ( [0] => meningitis ) [_transient_timeout_tribe_attendees] => Array ( [0] => 1488227821 ) [_transient_tribe_attendees] => Array ( [0] => a:0:{} ) [page_sections] => Array ( [0] => ) [_page_sections] => Array ( [0] => field_5a74c7ee071c2 ) [_yoast_wpseo_primary_category] => Array ( [0] => ) [_yoast_wpseo_content_score] => Array ( [0] => 30 ) [_yoast_wpseo_estimated-reading-time-minutes] => Array ( [0] => 2 ) [_yoast_wpseo_wordproof_timestamp] => Array ( [0] => ) [_yoast_wpseo_metadesc] => Array ( [0] => Monadnock Community Hospital (MCH) assures that it has not been affected by the CDC meningitis alert related to products from New England Compounding Pharmacy (NECC). MCH has a strong commitment to patient safety and promptly removed all NECC products before the FDA alert. ) [_yoast_wpseo_inclusive_language_score] => Array ( [0] => 90 ) )